142 related articles for article (PubMed ID: 33478201)
1. Expressions of ZNF436, β-catenin, EGFR, and CMTM5 in breast cancer and their clinical significances.
Chen Z; Cui N; Zhao JS; Wu JF; Ma F; Li C; Liu XY
Eur J Histochem; 2021 Jan; 65(1):. PubMed ID: 33478201
[TBL] [Abstract][Full Text] [Related]
2. [Expression and significance of CMTM5 and epidermal growth factor receptor in prostate cancer].
Yuan YQ; Zhang YX; Liu ZH; Qin CP; Sheng ZZ; Xu T; Wang XF
Beijing Da Xue Xue Bao Yi Xue Ban; 2015 Aug; 47(4):571-6. PubMed ID: 26284387
[TBL] [Abstract][Full Text] [Related]
3. CMTM5 inhibits the development of prostate cancer via the EGFR/PI3K/AKT signaling pathway.
Li L; Hu Y; Chen D; Zhu J; Bao W; Xu X; Chen H; Chen W; Feng R
Mol Med Rep; 2022 Jan; 25(1):. PubMed ID: 34791506
[TBL] [Abstract][Full Text] [Related]
4. β-Catenin nuclear localization positively feeds back on EGF/EGFR-attenuated AJAP1 expression in breast cancer.
Xu C; Liu F; Xiang G; Cao L; Wang S; Liu J; Meng Q; Xu D; Lv S; Jiao J; Niu Y
J Exp Clin Cancer Res; 2019 Jun; 38(1):238. PubMed ID: 31171012
[TBL] [Abstract][Full Text] [Related]
5. Reduced CMTM5 expression correlates with carcinogenesis in human epithelial ovarian cancer.
Li P; Liu K; Li L; Yang M; Gao W; Feng J; Lv Y; Qu X; Kong B
Int J Gynecol Cancer; 2011 Oct; 21(7):1248-55. PubMed ID: 21841490
[TBL] [Abstract][Full Text] [Related]
6. CMTM5 exhibits tumor suppressor activity through promoter methylation in oral squamous cell carcinoma.
Zhang H; Nan X; Li X; Chen Y; Zhang J; Sun L; Han W; Li T
Biochem Biophys Res Commun; 2014 May; 447(2):304-10. PubMed ID: 24721428
[TBL] [Abstract][Full Text] [Related]
7. [Research advances in CKLF-like MARVEL transmembrane domain containing member 5].
Yuan YQ; Xiao YB; Liu ZH; Zhang XW; Xu T; Wang XF
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2012 Dec; 34(6):625-8. PubMed ID: 23286412
[TBL] [Abstract][Full Text] [Related]
8. [CMTM5 inhibits the tumor cell behavior of prostate cancer by downregulation of HER2].
Xu T; Li J; Xiao YB; Liu ZH; Li Q; Wang XF
Beijing Da Xue Xue Bao Yi Xue Ban; 2010 Aug; 42(4):386-90. PubMed ID: 20721248
[TBL] [Abstract][Full Text] [Related]
9. [Abnormally lower expression of cmtm5 gene in bone marrow cells from patients with multiple myeloma].
Niu JH; Bao L; Zhang Y; Li JL; Li LD; Xie M; Qin YZ; Lai YY; Jiang Q; Shi HL; Liu YR; Jiang B; Chen SS; Huang XJ; Ruan GR
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Apr; 18(2):363-7. PubMed ID: 20416169
[TBL] [Abstract][Full Text] [Related]
10. High expression and localization of β-catenin and epidermal growth factor receptor identify high risk papillary thyroid carcinoma patients.
Išić Denčić T; Bartolome A; Šelemetjev S; Đorić I; Tatić S; Živaljević V; Cvejić D
Exp Mol Pathol; 2018 Oct; 105(2):181-189. PubMed ID: 30077672
[TBL] [Abstract][Full Text] [Related]
11. Up-regulation of miR-10b-3p promotes the progression of hepatocellular carcinoma cells via targeting CMTM5.
Guan L; Ji D; Liang N; Li S; Sun B
J Cell Mol Med; 2018 Jul; 22(7):3434-3441. PubMed ID: 29691981
[TBL] [Abstract][Full Text] [Related]
12. CMTM5 is reduced in prostate cancer and inhibits cancer cell growth in vitro and in vivo.
Xiao Y; Yuan Y; Zhang Y; Li J; Liu Z; Zhang X; Sheng Z; Xu T; Wang X
Clin Transl Oncol; 2015 Jun; 17(6):431-7. PubMed ID: 25387568
[TBL] [Abstract][Full Text] [Related]
13. CMTM5/7 are biomarkers and prognostic factors in human breast carcinoma.
Wu J
Cancer Biomark; 2020; 29(1):89-99. PubMed ID: 32568178
[TBL] [Abstract][Full Text] [Related]
14. Comparative immunohistochemical expression of β-catenin, EGFR, ErbB2, and p63 in adamantinomatous and papillary craniopharyngiomas.
Esheba GE; Hassan AA
J Egypt Natl Canc Inst; 2015 Sep; 27(3):139-45. PubMed ID: 26198262
[TBL] [Abstract][Full Text] [Related]
15. Frequent inactivation of MCC/CTNNBIP1 and overexpression of phospho-beta-catenin(Y654) are associated with breast carcinoma: Clinical and prognostic significance.
Mukherjee N; Dasgupta H; Bhattacharya R; Pal D; Roy R; Islam S; Alam N; Biswas J; Roy A; Roychoudhury S; Panda CK
Biochim Biophys Acta; 2016 Sep; 1862(9):1472-84. PubMed ID: 27208794
[TBL] [Abstract][Full Text] [Related]
16. [Inhibitory effect of CMTM5 on xenografted human prostatic cancer in nude mice].
Xiao YB; Xie J; Zhang GX; Li J; Hao YC; Zhang XW; Liu ZH; Xu T; Wang XF
Zhonghua Nan Ke Xue; 2012 Mar; 18(3):195-9. PubMed ID: 22474980
[TBL] [Abstract][Full Text] [Related]
17. Validation of aspirin response-related transcripts in patients with coronary artery disease and preliminary investigation on CMTM5 function.
Zhang JW; Liu TF; Chen XH; Liang WY; Feng XR; Wang L; Fu SW; McCaffrey TA; Liu ML
Gene; 2017 Aug; 624():56-65. PubMed ID: 28457985
[TBL] [Abstract][Full Text] [Related]
18. Akt1 inhibition promotes breast cancer metastasis through EGFR-mediated β-catenin nuclear accumulation.
Li W; Hou JZ; Niu J; Xi ZQ; Ma C; Sun H; Wang CJ; Fang D; Li Q; Xie SQ
Cell Commun Signal; 2018 Nov; 16(1):82. PubMed ID: 30445978
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of cyclin D1, β-catenin, and MTA1 in patients with invasive ductal carcinoma of the breast.
Cheng CW; Liu YF; Yu JC; Wang HW; Ding SL; Hsiung CN; Hsu HM; Shieh JC; Wu PE; Shen CY
Ann Surg Oncol; 2012 Dec; 19(13):4129-39. PubMed ID: 22864797
[TBL] [Abstract][Full Text] [Related]
20. Correlation between expression of LRP16, Ki67 and EGFR and breast cancer clinical pathologic factors and prognosis.
Yao DJ; Qiao S; Zhang Y; Zhao YT; Yuan CH
Eur Rev Med Pharmacol Sci; 2017 Jul; 21(3 Suppl):47-51. PubMed ID: 28745792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]